IndieBio is Now SOSV NY & SOSV SF, Underscoring SOSV’s Leadership in Deep Tech
In 2015, SOSV opened IndieBio San Francisco, Silicon Valley’s first biotech program that offered bio-labs as well as pre-seed investment to scientists ready to launch startups. IndieBio took the world by storm and biotech investing surged. In 2020, SOSV opened a second IndieBio in New York City. Between 2015 and 2025, IndieBio’s 310 graduates raised […]
Recent news
Announcing the SOSV Deep Tech Summit, coming November 4-6
The SOSV Deep Tech Summit focuses on three areas: climate tech, human health, and AI for the physical world.
Helex Raises $3.5M Seed to Advance Non-Viral Gene Therapies for Kidney Diseases
A new hope for patients with genetic kidney diseases. Helex, an SOSV portfolio company and graduate of the IndieBio startup development program, which is developing a new class of targeted medicines for genetic kidney disorders, announced its $3.5M Seed round, led by pi Ventures, with participation from Bluehill Capital, SOSV, and others. Helex is tackling […]